WHAT: New developments in the treatment of allergic diseases, asthma and immunologic disorders that afflict more than 50 million Americans will be presented. WHEN: November 12-17, 2004
WHERE: John B. Hynes Memorial Convention Center & the Sheraton Boston Hotel in Boston, Massachusetts
ONLINE: Program and faculty information is available at www.acaai.org.
TOPICS:
* Allergies and school performance: better grades through better treatment* Anaphylaxis: managing life-threatening reactions* Anti-IgE: affecting the antibody* Asthma: new developments and experts debate on eosinophils, neutrophils, lymphocytes, epithelial cells, smooth muscle or mast cells/basophils* Cat exposure: menace or friend?* Complementary and alternative medicine: What works and what doesn't in allergy and asthma care* Derm Fest: five track program on skin disorders including dermatitis, eczema, urticaria* Food allergy: prevention, sensitization and treatment* Immunotherapy: Collegium of topics including efficacy and new applications* Nonallergic disease: Can it be IgE mediated?* Rhinitis: impact on sleep, asthma and cognitive defects* Rhinosinusitis: topical medications and novel therapies
WHO: More than 4,000 meeting participants include some 1,800 physicians, 200 allied health professionals, 100 office managers and 1,200 pharmaceutical representatives.
The ACAAI is a professional medical organization, headquartered in Arlington Heights, Ill., comprising 4,900 qualified allergists-immunologists and related health care professionals. The College is dedicated to the clinical practice of allergy, asthma and immunology through education and research to promote the highest quality of patient care.
RSS